DNM2 and glioma: Specifically, in IDH mutant gliomas, this subregion more likely corresponds to low-malignancy tissues with relatively high vascular integrity, which may be attributed to the fact that the IDH mutation regulates downstream cytoskeletal protein (like Tau), inhibiting angiogenesis and promoting vascular normalization [7, 31].